X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
0
Other Certificates
Other Suppliers
0
USA (Orange Book)
0
Europe
Canada
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
0
Annual Reports
0
0
41
PharmaCompass offers a list of Betahistine Dihydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Betahistine Dihydrochloride manufacturer or Betahistine Dihydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Betahistine Dihydrochloride manufacturer or Betahistine Dihydrochloride supplier.
PharmaCompass also assists you with knowing the Betahistine Dihydrochloride API Price utilized in the formulation of products. Betahistine Dihydrochloride API Price is not always fixed or binding as the Betahistine Dihydrochloride Price is obtained through a variety of data sources. The Betahistine Dihydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Betahistine Dihydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Betahistine Dihydrochloride, including repackagers and relabelers. The FDA regulates Betahistine Dihydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Betahistine Dihydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Betahistine Dihydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Betahistine Dihydrochloride supplier is an individual or a company that provides Betahistine Dihydrochloride active pharmaceutical ingredient (API) or Betahistine Dihydrochloride finished formulations upon request. The Betahistine Dihydrochloride suppliers may include Betahistine Dihydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Betahistine Dihydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Betahistine Dihydrochloride DMF (Drug Master File) is a document detailing the whole manufacturing process of Betahistine Dihydrochloride active pharmaceutical ingredient (API) in detail. Different forms of Betahistine Dihydrochloride DMFs exist exist since differing nations have different regulations, such as Betahistine Dihydrochloride USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Betahistine Dihydrochloride DMF submitted to regulatory agencies in the US is known as a USDMF. Betahistine Dihydrochloride USDMF includes data on Betahistine Dihydrochloride's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Betahistine Dihydrochloride USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Betahistine Dihydrochloride suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Betahistine Dihydrochloride Drug Master File in Korea (Betahistine Dihydrochloride KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Betahistine Dihydrochloride. The MFDS reviews the Betahistine Dihydrochloride KDMF as part of the drug registration process and uses the information provided in the Betahistine Dihydrochloride KDMF to evaluate the safety and efficacy of the drug.
After submitting a Betahistine Dihydrochloride KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Betahistine Dihydrochloride API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Betahistine Dihydrochloride suppliers with KDMF on PharmaCompass.
A Betahistine Dihydrochloride CEP of the European Pharmacopoeia monograph is often referred to as a Betahistine Dihydrochloride Certificate of Suitability (COS). The purpose of a Betahistine Dihydrochloride CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Betahistine Dihydrochloride EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Betahistine Dihydrochloride to their clients by showing that a Betahistine Dihydrochloride CEP has been issued for it. The manufacturer submits a Betahistine Dihydrochloride CEP (COS) as part of the market authorization procedure, and it takes on the role of a Betahistine Dihydrochloride CEP holder for the record. Additionally, the data presented in the Betahistine Dihydrochloride CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Betahistine Dihydrochloride DMF.
A Betahistine Dihydrochloride CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Betahistine Dihydrochloride CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Betahistine Dihydrochloride suppliers with CEP (COS) on PharmaCompass.
A Betahistine Dihydrochloride written confirmation (Betahistine Dihydrochloride WC) is an official document issued by a regulatory agency to a Betahistine Dihydrochloride manufacturer, verifying that the manufacturing facility of a Betahistine Dihydrochloride active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Betahistine Dihydrochloride APIs or Betahistine Dihydrochloride finished pharmaceutical products to another nation, regulatory agencies frequently require a Betahistine Dihydrochloride WC (written confirmation) as part of the regulatory process.
click here to find a list of Betahistine Dihydrochloride suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Betahistine Dihydrochloride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Betahistine Dihydrochloride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Betahistine Dihydrochloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Betahistine Dihydrochloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Betahistine Dihydrochloride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Betahistine Dihydrochloride suppliers with NDC on PharmaCompass.
Betahistine Dihydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Betahistine Dihydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Betahistine Dihydrochloride GMP manufacturer or Betahistine Dihydrochloride GMP API supplier for your needs.
A Betahistine Dihydrochloride CoA (Certificate of Analysis) is a formal document that attests to Betahistine Dihydrochloride's compliance with Betahistine Dihydrochloride specifications and serves as a tool for batch-level quality control.
Betahistine Dihydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Betahistine Dihydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Betahistine Dihydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Betahistine Dihydrochloride EP), Betahistine Dihydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Betahistine Dihydrochloride USP).
Market Place
